The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients

This publication has 18 references indexed in Scilit:

• Lack of an association between 5-HT1A receptor gene structural polymorphisms and suicide victims
  American Journal of Medical Genetics, 2002
• Augmentation of Fluoxetine's Antidepressant Action by Pindolol: Analysis of Clinical, Pharmacokinetic, and Methodologic Factors
  Journal of Clinical Psychopharmacology, 2001
• Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists
  Trends in Neurosciences, 1996
• Mood disorders in the general population represent an important and worldwide public health problem
  International Clinical Psychopharmacology, 1995
• Systematic screening for mutations in the promoter and the coding region of the 5‐HT_1A gene
  American Journal of Medical Genetics, 1995
• 2 Naturally Occurring Amino Acid Substitutions in the Human 5-HT1A Receptor: Glycine 22 to Serine 22 and Isoleucine 28 to Valine 28
  Biochemical and Biophysical Research Communications, 1995
• Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis
  Life Sciences, 1994
• Current advances and trends in the treatment of depression
  Trends in Pharmacological Sciences, 1994
• Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
  International Clinical Psychopharmacology, 1994
• Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei
  Synapse, 1993